Abstract Activation of serotonin 5-HT 4 receptors has pro-cognitive effects on memory performance. The proposed underlying neurochemical mechanism is the enhancement of acetylcholine release in frontal cortex and hippocampus elicited by 5-HT 4 agonists. Although 5-HT 4 receptors are present in brain areas related to cognition, e.g., hippocampus and cortex, the cellular localization of the receptors that might modulate acetylcholine release is unknown at present. We have analyzed, using dual label in situ hybridization, the cellular localization of 5-HT 4 receptor mRNA in identified neuronal populations of the rat basal forebrain, which is the source of the cholinergic innervation to cortex and hippocampus. 5-HT 4 receptor mRNA was visualized with isotopically labeled oligonucleotide probes, whereas cholinergic, glutamatergic, GABAergic and parvalbumin-synthesizing neurons were identified with digoxigenin-labeled oligonucleotide probes. 5-HT 4 receptor mRNA was not detected in the basal forebrain cholinergic cell population. In contrast, basal forebrain GABAergic, parvalbumin synthesizing, and glutamatergic cells contained 5-HT 4 receptor mRNA. Hippocampal and cortical glutamatergic neurons also express this receptor. These results indicate that 5-HT 4 receptors are not synthesized by cholinergic cells, and thus would be absent from cholinergic terminals. In contrast, several non-cholinergic cell populations within the basal forebrain and its target hippocampal and cortical areas express these receptors and are thus likely to mediate the enhancement of acetylcholine release elicited by 5-HT 4 agonists.
Introduction
The existence of the serotonin 5-HT 4 receptor family was first proposed in 1988, when a serotonin receptor was observed in cultures of mouse colliculi, which was able to stimulate adenylate cyclase and was insensitive to antagonists of the three serotonin receptor families described until then, i.e., 5-HT 1 , 5-HT 2 , and 5-HT 3 (Dumuis et al. 1988 ). This and several other lines of evidence from different laboratories (see Ford and Clarke 1993 for a review) resulted in the unequivocal establishment of the presence of 5-HT 4 receptors in many other CNS regions and peripheral organs (reviewed in Eglen et al. 1995; Hegde and Eglen 1996; Eglen and Hegde 1996) .
Serotonin 5-HT 4 receptors were first cloned in rat, where two splice variants were described, differing after Leu358 in the length and sequence of the carboxy terminus, and termed 5-HT 4S and 5-HT 4L for short and long, respectively (Gerald et al. 1995) . Subsequent cloning efforts in other species (Blondel et al. 1998; Claeysen et al. 1998 Claeysen et al. , 1999 showed the existence of additional C-terminal splice variants, and this prompted the adoption of the alphabetical nomenclature, by which 5-HT 4S and 5-HT 4L became 5-HT 4(a) and 5-HT 4(b), respectively. At present, and including all the isoforms cloned in three mammalian species (human, rat and mouse), nine different C-terminal splice variants and one internal splice variant have been cloned (Bender et al. 2000; Vilaró et al. 2002; Bockaert et al. 2004; Brattelid et al. 2004; Ray et al. 2009 ).
Notable among the diverse behavioral effects elicited by pharmacological interventions on 5-HT 4 receptors is the pro-cognitive effect of 5-HT 4 agonists, which seem to be able to modulate several aspects of memory performance (acquisition, consolidation, reversal of induced deficits) (see Bockaert et al. 2004; Perez-Garcia and Meneses 2008 and references therein) . A putative neuroanatomical substrate for this modulation is provided by the presence of 5-HT 4 receptors in several brain regions involved in learning and memory, i.e., hippocampus, cortex, basal forebrain (Waeber et al. 1994; Patel et al. 1995; Reynolds et al. 1995; Compan et al. 1996; Bonaventure et al. 2000; Varnas et al. 2003; Vilaró et al. 2005; Marner et al. 2009 ). On the other hand, the underlying neurochemical mechanism for these pro-cognitive effects has been proposed to be the enhancement of acetylcholine release in cortical and hippocampal regions by 5-HT 4 receptor stimulation (Consolo et al. 1994; Yamaguchi et al. 1997a, b; Siniscalchi et al. 1999; Matsumoto et al. 2001) . This has prompted the suggestion that 5-HT 4 receptor agonists, alone or in combination with acetylcholinesterase inhibitors, might be valuable therapeutic tools for the treatment of cognitive deficits associated with impairment of the cholinergic system due to normal aging or pathological situations such as Alzheimer's disease (Moser et al. 2002; Lamirault et al. 2003; Bockaert et al. 2004 ). However, the precise cellular localization of the 5-HT 4 receptors that may mediate the effects on the cholinergic system is unknown. Therefore, in the present study we have analyzed the sites of synthesis of 5-HT 4 receptors that may be related with cholinergic function and cognitive performance by studying the cellular localization of their mRNA in different identified neuronal populations in the basal forebrain (BF) and its hippocampal target areas.
Experimental procedures

Tissue preparation
Adult male Wistar rats weighting 200-300 g (n = 6) were purchased from Iffa Credo (Lyon, France). Animal care followed the Spanish legislation on ''Protection of animals used in experimental and other scientific purposes'' in agreement with the European regulations (European Communities Council directive 86/609/EEC of November 24 1986 [O.J. of E.C. L358, 18/12/1986] ). Experimental procedures were approved by the required ethical committees and local authorities.
Animals were killed by decapitation. The brains were quickly removed, frozen on dry ice and kept at -20°C. Tissue sections, 20-lm thick, were cut on a microtomecryostat (Microm HM500 OM, Walldorf, Germany), thawmounted onto APTS (3-aminopropyltriethoxysilane; Sigma, St Louis, MO, USA) coated slides, and kept at -20°C until used for in situ hybridization or for acetylcholinesterase staining. The latter was done as previously described (Vilaró et al. 1992) . The anatomical levels included in the hybridization studies spanned all the rostrocaudal extent of the basal forebrain where cholinergic cells are located.
Hybridization probes
For the detection of 5-HT 4 receptor mRNA, six different oligodeoxyribonucleotides (50 nucleotides long) were used simultaneously. They were complementary to the following bases of the rat 5-HT 4 receptor mRNA (Gerald et al. 1995) (base numbering corresponds to the sequence of the 5-HT 4(a) splice variant, GenBank accession number U20906): r5HT4N, bases 21-70; r5HT4SL, bases 960-1,009; r5-HT4SL/2, bases 683-732; r5-HT4SL/3, bases 741-790; r5HT4SL/4, bases 1,029-1,078; r5HT4SL/ 5, bases 258-307. All these regions of the mRNA are common to all four splice variants (r5-HT 4(a) , r5-HT 4(b) , r5-HT 4(c1) , and r5-HT 4(e) ) cloned to date in the rat (Gerald et al. 1995; Claeysen et al. 1999; Ray et al. 2009 ).
Cholinergic cells were visualized by the presence of the mRNA for the enzyme choline acetyltransferase (ChAT). Two oligonucleotides complementary to bases 571-618 and 1,321-1,368 of the rat ChAT cDNA sequence (Ishii et al. 1990 ) were used. GABAergic cells were identified by the presence of the mRNA for the GABA-synthesizing enzyme GAD65 (glutamic acid decarboxylase, isoform of molecular weight 65 kDa). Two oligonucleotides complementary to rat GAD65 mRNA were made, corresponding to bases 159-213 and 514-558 (GenBank accession number NM_012563). Neurons containing parvalbumin mRNA were identified with two oligonucleotides complementary to bases 175-215 and 264-308 (GenBank accession number M12725) of rat parvalbumin mRNA. Finally, cells containing mRNA for the vesicular glutamate transporter vGLUT2 (putatively glutamatergic) were also identified with six oligonucleotides complementary to bases 311-355, 466-510, 530-574, 2,072-2,116, 2,156-2,200 , and 2,356-2,400 (GenBank accession number AF271235).
The oligonucleotides were all synthesized and HPLC purified by Isogen Bioscience BV (Maarsden, The Netherlands). Comparison of the oligonucleotide sequences with EMBL and GenBank databases with Basic Local Alignment Search Tool (BLAST) indicated that the probes did not show any significant similarity with mRNAs other than their corresponding targets in the rat.
Oligonucleotides for 5-HT 4 receptor mRNA were labeled at their 3 0 -end using [ 33 P] a-dATP (3,000 Ci/mmol, New England Nuclear, Boston, MA, USA) and terminal deoxynucleotidyl transferase (TdT) (Oncogene Research Products, San Diego, CA, USA). Oligonucleotides for ChAT, GAD65, vGLUT2 and parvalbumin (100 pmol) were non-radioactively labeled at their 3 0 -end with TdT (recombinant, Roche Applied Science, Penzberg, Germany) and digoxigenin-labeled nucleotides (Dig-11-dUTP, Roche Applied Science, Mannheim, Germany) according to a previously described procedure (Schmitz et al. 1991) . Labeled probes were purified from non-incorporated nucleotides with ProbeQuant G-50 micro columns (GE Healthcare, Little Chalfont, UK).
In situ hybridization histochemistry procedure
The protocols for single-and double-label in situ hybridization histochemistry were based on previously described procedures (Vilaró et al. 1996; Landry et al. 2000; Serrats et al. 2003) . Frozen tissue sections were brought to room temperature, fixed for 20 min at 4°C in 4 % paraformaldehyde in phosphate-buffered saline (19 PBS: 8 mM Na 2 HPO 4 , 1.4 mM KH 2 PO 4 , 136 mM NaCl, 2.6 mM KCl), washed for 5 min in 39 PBS, twice for 5 min each in 19 PBS at room temperature, and incubated for 2 min at 21°C in a freshly prepared solution of predigested pronase (Calbiochem, San Diego, CA, USA) at a final concentration of 24 U/ml in 50 mM Tris-HCl pH 7.5, 5 mM EDTA. Proteolytic activity was stopped by immersion for 30 s in 2 mg/ml glycine in 19 PBS. Tissues were finally rinsed in 19 PBS and dehydrated through 70 and 100 % ethanol. For hybridization, radioactively and non-radioactively labeled probes were diluted in a solution containing 50 % formamide, 49 SSC (19 SSC: 150 mM NaCl, 15 mM sodium citrate), 19 Denhardt's solution (0.02 % Ficoll, 0.02 % polyvinylpyrrolidone, 0.02 % bovine serum albumin), 10 % dextran sulfate, 1 % sarkosyl, 20 mM phosphate buffer pH 7.0, 250-lg/ml yeast tRNA and 500-lg/ml salmon sperm DNA. The final concentrations of radioactive and Dig-labeled probes in the hybridization buffer were in the same range (approximately 1.5-2 nM each probe). Tissue sections were covered with 60-70 ll of hybridization solution containing the labeled probes, overlaid with Nescofilm coverslips (Bando Chemical Ind, Kobe, Japan) and incubated overnight at 42°C in humid boxes. Sections were washed four times (45 min each) in 0.6 M NaCl, 10 mM Tris-HCl pH 7.5 at 60°C. Sections hybridized with 33 P-and Dig-labeled probes simultaneously were washed in the same buffer at room temperature for 10 min, whereas sections hybridized with radioactive probes only were dehydrated through 70 and 100 % ethanol and allowed to air dry.
Development of radioactive and non-radioactive hybridization signal
Sections hybridized with 33 P-and Dig-labeled probes were treated as described by Landry et al. (2000) . Thus, after washing, the slides were immersed for 30 min in a buffer containing 0.1 M Tris-HCl pH 7.5, 1 M NaCl, 2 mM MgCl 2 and 0.5 % bovine serum albumin (Fraction V, Sigma-Aldrich) and incubated overnight at 4°C in the same solution containing an alkaline-phosphatase-conjugated anti-digoxigenin antibody (Fab fragments, 1:5,000 dilution; Roche Applied Science, Penzberg, Germany). Afterwards, they were washed three times (10 min each) in the same buffer, and twice (10 min each) in an alkaline buffer containing 0.1 M Tris-HCl pH 9.5, 0.1 M NaCl, and 5 mM MgCl 2 . Alkaline phosphatase activity was developed by incubating the sections with 3.3 mg nitroblue tetrazolium and 1.65 mg bromochloroindolyl phosphate (Roche Applied Science, Penzberg, Germany) diluted in 10 ml of alkaline buffer overnight at room temperature in the dark. The enzymatic reaction was stopped by washing three times, 10 min each, in the alkaline buffer containing 1 mM EDTA. The sections were then briefly dipped in water, 70 and 100 % ethanol, and air-dried. Sections incubated with Dig-labeled probes were dipped in a solution of 2 % collodion in amyl acetate (Electron Microscopy Sciences, Hatfield, PA, USA) and allowed to dry. All sections were dipped into Ilford K5 nuclear emulsion (Harman Technology Ltd, Mobberley, Cheshire, UK) diluted 1:1 with distilled water. They were exposed in the dark at 4°C for 6 weeks, and finally developed in Kodak D19 (Kodak, Rochester, NY, USA) for 5 min, and fixed in Ilford Hypam fixer (Harman Technology Ltd, Mobberley, Cheshire, UK).
Controls for specificity of hybridization signals
Several routine control experiments are performed with all the oligonucleotide probes used for in situ hybridization in our laboratory. In brief, the following controls were performed (not shown): (a) When two or more probes aimed at the same mRNA species were used independently as hybridization probes in consecutive sections, identical patterns of hybridization signal were observed. (b) For any given labeled probe, inclusion during hybridization of an excess of the same unlabeled oligonucleotide resulted in absence of specific hybridization signals. The autoradiographic signal remaining under these conditions was taken as nonspecific tissue signal. (c) Inclusion during hybridization of an excess of an unrelated unlabeled oligonucleotide left specific hybridization signals unaffected. (d) The thermal stability of the hybrids was studied by washing a series of consecutive sections at increasing temperatures. The intensity of specific signals suffered a very sharp decrease as washing temperature increased, whereas no such sharp decrease was observed in background levels of signal.
Analysis of the results
The anatomical levels included in the hybridization studies spanned all the rostrocaudal extent of the basal forebrain where cholinergic cells are located, from the very anterior pole of the nucleus of the vertical limb of the diagonal band (approximate Bregma level ?1.6 mm) to the more caudal extent of the basal nucleus of Meynert (approximate Bregma -2.8 mm) (Paxinos and Watson 1998) .
Tissue sections were examined under bright-and darkfield illumination in a Wild 420 macroscope (Leica, Heerbrugg, Germany), and in a Zeiss Axioplan microscope (Zeiss, Oberkochen, Germany) or in a Nikon Eclipse E1000 microscope (Nikon, Tokyo, Japan) equipped with bright-and dark-field condensers for transmitted light. A Darklite illuminator (Micro Video Instruments, Avon, MA, USA) was used in some instances to improve the visualization of autoradiographic silver grains and to capture bright-and dark-field images simultaneously.
Cholinergic-, GABAergic-, glutamatergic-, and parvalbumin-containing neurons were identified as cellular profiles exhibiting a dark precipitate (alkaline phosphatase reaction product). 5-HT 4 receptor mRNA hybridization signal was considered positive when visually identified accumulation of silver grains over the stained cellular profiles, or unstained areas of similar surface, was estimated by microscopic visual inspection to be approximately threefold higher than the background levels of signal in regions known to be devoid of 5-HT 4 receptor mRNA. In all the experiments, control sections were included that were incubated with the labeled probes, both isotopically and digoxigenin labeled, plus a large excess of the same unlabeled oligonucleotides. These sections served as control for specificity of positive signals.
For qualitative analysis, and for any given combination of probes, microscopic inspection was performed on multiple sections spanning all the rostrocaudal extent of the basal forebrain where cholinergic cells are located. For quantitative analysis, two anatomical coronal levels were chosen therein for cell counting, one at an approximate distance from Bregma of ?0.20 mm (according to Paxinos and Watson 1998) which includes the medial septum (MS), the vertical limb of the diagonal band (VDB) and the rostral part of the horizontal limb of the diagonal band (HDB) (Fig. 1a) , and a second one at an approximate distance from Bregma of -0.30 mm, where the caudal portion of the HDB coexists with the more laterally located magnocellular preoptic nucleus (MCPO) (Fig. 1b) . Cell counting was performed in these regions because they contain a complex mixture of different neuronal phenotypes and it was of interest to have a quantitative estimate of the magnitude of 5-HT 4 receptor expression in the different cell populations. Number of counted cells (Table 1) in the MS and VDB is presented as aggregate numbers, due to the diffuse boundaries between these two areas. Counted cells in the HDB include cells counted at both rostrocaudal levels of this structure. Cell counting was performed as follows. Dark-and bright-field digital photomicrographs were taken with the 109 objective of a Zeiss Axioplan microscope equipped with a digital camera (DXM1200 F, Nikon) and ACT-1 Nikon Software. For any given tissue section, photographs were taken from as many contiguous microscopic fields as necessary to encompass all the extent of the region of interest. The borders of the different subregions to be analyzed (MS, VDB, HDB) were defined as follows. For a given anatomical level, a photomontage was obtained with all the contiguous bright-field photomicrographs of the ChAT-hybridized (or sometimes the GAD65-hybridized) tissue section. It was printed at low magnification and the borders were drawn on these prints with the help of the anatomical atlas (Paxinos and Watson 1998) and considering the known distribution of cholinergic and/ or GABAergic cells in the basal forebrain. The boundaries drawn were considered later for cell counting in the individual photomicrographs viewed at higher magnification. Labeled cells were counted with the help of the program AnalySIS (Soft Imaging Systems GmbH, Germany), which allowed the superimposition of the bright-and dark-field images of the same microscopic field. Visual inspection of the superimposed image on the computer screen allowed manual cell counting. For each neurochemical marker and anatomical level, 2-3 animals (1-2 sections/animal) were counted. Three types of cells were considered: (a) doubly labeled cells showing dark precipitate, indicative of positive signal for the mRNA of the different neurochemical markers, plus accumulation of silver grains, indicating positive signal for 5-HT 4 receptor mRNA; (b) cells showing signal for 5-HT 4 receptor mRNA only, i.e., accumulation of silver grains over precipitate-free tissue areas similar in size to nearby stained cellular profiles; (c) cells showing signal for the neurochemical marker only.
Preparation of figures
Microphotography was performed as described above.
Figures were prepared for publication using Adobe Photoshop software (Adobe Software, San Jose, CA, USA).
Contrast and brightness of the images were adjusted digitally if necessary. Some of the illustrations of labeled cells at high magnification were prepared with the help of some features of the Photoshop software as follows. Dark-and bright-field photomicrographs (209 objective) were taken from the area to be illustrated. The dark-field image was inverted with the Photoshop software, so that silver grains were seen dark on a white background. The inverted image was superimposed on the bright-field image showing the digoxigenin-labeled cells, and both images were blended with the Multiply option selected. The area to be illustrated in more detail was then selected from this blended image and scaled up as convenient.
Results
The regional distribution of 5-HT 4 receptor mRNA observed in the present study was in agreement with our previous studies (Vilaró et al. 1996 (Vilaró et al. , 2005 . Thus, the highest levels of hybridization signal were observed in the olfactory tubercle, hippocampus and caudate-putamen. In comparison with these regions, the intensity of the hybridization signal observed in the basal forebrain cholinergic projection system, i.e., in the medial septum/diagonal band (MS/DB) complex ( Fig. 1 ) and nucleus basalis of Meynert (NbM), was of much lower intensity. Given this lower signal intensity in these regions of interest, some considerations on the sensitivity of our method are warranted here. Since we were aware from our previous studies that the levels of 5-HT 4 receptor mRNA expression were low in the basal forebrain (Vilaró et al. 2005) , we chose to increase the sensitivity of our method by increasing the number of different oligonucleotide probes complementary to 5-HT 4 receptor mRNA. Thus, six different probes directed to different regions of the mRNA were used simultaneously in the present study as compared to our previous studies where one (Vilaró et al. 1996) or two (Vilaró et al. 2005) probes had been used. With this approach, sensitivity was improved, as evidenced by the higher number of cells positive for 5-HT 4 mRNA as compared to our previous study. This was, however, at expenses of generating increased levels of tissue background due to the use of higher concentrations of radioactively labeled probe during tissue hybridization. Nevertheless, the signal-to-noise ratio was still good enough and labeled cells were easily discernible from background levels of signal.
5-HT 4 receptor mRNA-containing cells and cholinergic cells in the MS/DB complex and NbM
In the MS/DB complex, 5-HT 4 receptor mRNA-containing cells displayed a more widespread and homogeneous distribution when compared to ChAT mRNA-positive cells.
In the MS and in the vertical limb of the diagonal band (VDB), cholinergic cells were distributed in a band-like fashion, i.e., concentrated in the midline region and in a band located laterally to these midline neurons, with a region in between where cholinergic cells were more scarce. In contrast, 5-HT 4 receptor mRNA-positive cells were distributed more homogeneously and were present in regions more lateral than the laterally located cholinergic cells. A similar situation was observed in the horizontal limb of the diagonal band (HDB) at rostral levels, where ChAT mRNA-positive cells were often seen in a ringshaped distribution, whereas 5-HT 4 receptor mRNA-positive cells were more homogeneously distributed, also in the inner regions of the ring formed by cholinergic cells. At more caudal levels, where the HDB coexists with the contiguous, more laterally located magnocellular preoptic nucleus (MCPO), 5-HT 4 receptor mRNA-positive cells were observed scattered in both nuclei, whereas cholinergic cells were particularly concentrated in the HDB. Cell counting in tissue sections doubly labeled for 5-HT 4 receptor mRNA and ChAT mRNA (Table 1) indicated that 5-HT 4 receptor mRNA-positive cells (a total of 794 cells of this type were counted) were much more numerous than ChAT mRNA-positive cells (a total of 348 cells of this type were counted) in all the regions analyzed (MS/VDB and HDB). However, we did not observe any population of cells labeled simultaneously for both mRNAs in these areas. In other words, 5-HT 4 receptor mRNA was not detected in ChAT mRNA-positive, i.e., cholinergic, cells (Fig. 2) . All along the rostrocaudal extent of the nucleus basalis of Meynert (NbM), 5-HT 4 receptor mRNA-positive cells were observed intermingled with, and often in close proximity to, ChAT mRNA-positive cells, but no doubly labeled cells were found ( Fig. 3a-d) . In contrast, in sections consecutive or very close to the ones hybridized with probes for ChAT mRNA, double labeling indicated that these 5-HT 4 receptor mRNA-positive cells were GABAergic as shown by their expression of GAD65 mRNA ( Fig. 3e-h) . No attempt of cell counting was performed in the NbM due to the diffuse limits of this nucleus.
5-HT 4 receptor mRNA-containing cells and GABAergic cells in the MS/DB complex and NbM
In the MS/DB complex, GABAergic cells were identified by their expression of mRNA for the GABA-synthesizing enzyme GAD65 (Fig. 4) . They were more numerous and displayed a more homogeneous distribution when compared with cholinergic cells. Cell counting in tissue sections doubly labeled for 5-HT 4 receptor mRNA and GAD65 mRNA indicated that approximately one-half of the cells expressing 5-HT 4 receptor mRNA in the MS/VDB also expressed mRNA for GAD65, i.e., were GABAergic. Thus, of a total of 743 5-HT 4 receptor mRNA-positive cells that were counted in the MS/VDB, 352 of these cells were also labeled by GAD65 mRNA probes. In the HDB, both at rostral and more caudal levels where it coexists with the MCPO, approximately two-thirds of the 5-HT 4 receptor mRNA-positive cells were GABAergic (836 cells positive for 5-HT 4 receptor mRNA were counted, of which 578 were also labeled by GAD65 mRNA probes). In all the regions, around 50 % of the GABAergic cells contained 5-HT 4 receptor mRNA (Table 1) .
As stated above, 5-HT 4 receptor mRNA-positive cells in the region of the NbM were shown to express GAD65 mRNA ( Fig. 3e-h ). For any given region and marker, numbers represent total number of cells that express the mRNAs indicated in 2-3 different tissue sections. Presence or absence of the corresponding mRNA is indicated by ? and -, respectively (Freund 1989; Gritti et al. 2003) . Probes for PV mRNA were thus used in the present study to identify this population of GABAergic projection neurons (Fig. 5) . PV mRNA-positive cells were much less numerous than GAD65 mRNA-containing neurons. In sections doubly labeled for 5-HT 4 receptor mRNA and PV mRNA, of the cells positive for 5-HT 4 receptor mRNA in MS/VDB and HDB (936 and 293 counted cells, respectively), around 10-15 % was also positive for PV mRNA (74 and 43 cells, respectively). Of the cells positive for PV mRNA in the MS/VDB, around 20-30 % were also positive for 5-HT 4 receptor mRNA, whereas at more caudal levels of the HDB, the percentage was close to 50 % (Table 1) .
5-HT 4 receptor mRNA-containing cells and glutamatergic cells in the MS/DB complex
The MS/DB complex contains a population of glutamatergic cells that express the vesicular glutamate transporter vGLUT2 (Lin et al. 2003; Hur and Zaborszky 2005) . We have identified this population with probes for vGLUT2 mRNA (Fig. 6) . Cell counting in sections doubly labeled for vGLUT2 mRNA and 5-HT 4 receptor mRNA indicated that in the MS/VDB and HDB, around 20 % of the cells positive for 5-HT 4 receptor mRNA were also positive for vGLUT2 mRNA (a total of 889 cells positive for 5-HT 4 receptor mRNA were counted, of which 188 were also labeled by vGLUT2 mRNA probes). Of the cells positive for vGLUT2 mRNA, around 40 and 70 % were also positive for 5-HT 4 receptor mRNA in the MS/VDB and HDB, respectively (Table 1) .
5-HT 4 receptor mRNA-containing cells in the hippocampus
The hippocampus is, together with the olfactory tubercle and the caudate-putamen, the region of the rat brain presenting the strongest hybridization signal for 5-HT 4 receptor mRNA (Vilaró et al. 2005) , with very strong signals detected over the pyramidal cell layer of the CA subfields and the granule cell layer of the dentate gyrus. Nissl staining of sections hybridized with radioactive probes for 5-HT 4 receptor mRNA confirmed that the vast majority of the cellular profiles observed in these cell layers were strongly labeled (Fig. 7) , thus indicating that most of the pyramidal and granule cells express this receptor.
Hippocampal GABAergic neurons, that include interneurons and projection neurons (Freund and Buzsaki 1996) , were identified by their expression of GAD65 mRNA. In tissue sections doubly labeled for 5-HT 4 receptor mRNA and GAD65 mRNA, 5-HT 4 receptor mRNA was never observed to be present in GABAergic hippocampal neurons of the CA subfields and dentate gyrus (Fig. 8) .
5-HT 4 receptor mRNA-containing cells in the lateral septum
The lateral septum, which is a component of the septohippocampal-septal loop was also analyzed. 5-HT 4 receptor mRNA was strongly expressed in most of the GABAergic neurons of the dorsal part of the lateral septal nucleus (Fig. 9) .
Discussion
The main finding of the present in situ hybridization study is that cholinergic neurons of the MS/DB complex and NbM do not express detectable levels of serotonin 5-HT 4 receptor mRNA. In contrast, 5-HT 4 receptor mRNA is readily detectable in GABAergic, glutamatergic and parvalbumin-containing neurons in the MS/DB complex and in GABAergic neurons within the region of the NbM.
Technical aspects
Some technical considerations regarding the sensitivity of the technique are warranted before proceeding to further anatomical and functional considerations. When reporting negative results from in situ hybridization experiments, an issue to be considered is the sensitivity of the probes used. A priori, oligonucleotide probes are less sensitive than, for example, riboprobes (i.e., RNA probes obtained by transcription of cloned fragments of the receptor cDNA). However, one way of overcoming this limitation and increasing the sensitivity of oligonucleotide-based in situ hybridization is by the simultaneous use of multiple oligonucleotide probes complementary to different regions of the same receptor mRNA. In our experience, we have observed this fact by simply increasing the number of oligonucleotide probes for a given mRNA from one to two. This was the case, for example, for ChAT mRNA (Vilaró et al. 1992 (Vilaró et al. , 1994 ) and for 5-HT 4 receptor mRNA in our two previous studies [compare, for example, figure 2A in (Vilaró et al. 1996) with figure 1F in (Vilaró et al. 2005) ]. In the present study, we have further increased to six the number of probes used simultaneously for the detection of 5-HT 4 receptor mRNA, and this has resulted in an increased sensitivity when compared to our previous study (Vilaró et al. 2005) , especially in the regions of relatively low receptor expression such as, for example, the MS/DB complex. To our knowledge, there is no study available reporting the distribution of 5-HT 4 receptor mRNA in rat brain detected with riboprobes, thus precluding a comparison of the sensitivities of both approaches. However, data in the literature indicate that a multi-oligoprobe approach can be as sensitive as a riboprobe to detect mRNA expression in brain (Broide et al. 2004 ).
Anatomical considerations
Basal forebrain (BF) neurons, with their projections to hippocampal and cortical areas, are thought to play important roles in cognitive processes (Baxter and Chiba 1999) . The cholinergic component of the BF projection system was the first to be acknowledged as playing an important role (see Fibiger 1991; Wenk 1997; Gold 2003 for reviews), but subsequently other neurochemically distinct components were described in the basal forebrain, such as the GABAergic (reviewed in Sarter and Bruno 2002) and, more recently, the glutamatergic cell populations Lin et al. 2003) . These noncholinergic components may also be important for cognitive processes as illustrated by the fact that selective cholinergic lesions of the BF in rats produce less severe cognitive deficits than do more generalized, non-selective lesions of the same areas (Dunnett et al. 1991; Lee et al. 1994; Parent and Baxter 2004) .
Much is known about the interconnections between the BF and its different cortical and hippocampal targets. A summary is provided in the following paragraphs and in Fig. 10 . A major projection component in the BF is accounted for by the cholinergic projection neurons, which form a continuous cell column extending from the MS/DB complex rostrally, through the magnocellular preoptic area/ substantia innominata region and including the NbM more caudally (Schwaber et al. 1987) . The projection patterns of these cholinergic neurons have been extensively studied. Thus, the MS/VDB complex (the cholinergic cell groups Ch1 and Ch2 according to ) project mainly to hippocampal areas, the HDB (Ch3 group) projects mainly to the olfactory bulb, and more caudally located cholinergic cells in the substantia innominata/NbM region (Ch4 group) provide projections to the different cortical areas Woolf et al. 1984) . A second major neuronal component of BF is composed of GABAergic neurons, which greatly outnumber cholinergic cells in rat BF (Zaborszky et al. 1999) . A fraction of the BF GABAergic cells are projection neurons and express the calcium-binding protein parvalbumin (PV) and others are GABAergic interneurons (Freund 1989; Brauer et al. 1991; Gritti et al. 1993) . PV-containing GABAergic projection neurons innervate both hippocampal (Freund 1989; Kiss et al. 1990 ) and cortical targets . A population of putative glutamatergic cells has been described in rat BF on the basis of the presence of different glutamatergic markers Colom et al. 2005 ) and in particular of vesicular glutamate transporter 2 (vGLUT2) (Lin et al. 2003; Hur and Zaborszky 2005) . Some of these glutamatergic cells are projection neurons that project to hippocampus ) and cortical areas Manns et al. 2001; Hur and Zaborszky 2005; Henny and Jones 2008) , whereas a major proportion may represent local circuit neurons Manseau et al. 2005) .
In addition to their projections to cortical and hippocampal areas, all three classes of neurons, i.e., cholinergic, GABAergic and glutamatergic BF neurons participate in local axonal projections in the BF. Thus, MS/DB complex cholinergic neurons send local axon collaterals that contact septal GABAergic (Leranth and Frotscher 1989; Brauer et al. 1998) or parvalbumin-containing neurons ) and, similarly, cholinergic BF neurons are contacted by GABAergic terminals (Leranth and Frotscher 1989; Gritti et al. 1993) which may, at least in part, originate from local GABAergic interneurons Pang et al. 1998; Zaborszky and Duque 2000) . In addition, glutamatergic (i.e., vGLUT2 expressing) terminals of a predominant intrinsic origin have been described to make synaptic contacts with parvalbumin-containing Hajszan et al. 2004 ) and cholinergic septohippocampal neurons .
In turn, the cortical and hippocampal targets of the basal forebrain project back to the basal forebrain. Thus, the hippocampus projects directly to the MS/DB complex (Alonso and Kohler 1982; Gaykema et al. 1991a ) by way of connections from GABAergic non-pyramidal projection neurons in CA fields . The targets in the MS/DB complex of these hippocampo-septal fibers are mainly parvalbumin positive, GABAergic projection neurons and to a lesser extent cholinergic cells Toth et al. 1993 ). These hippocampo-septal fibers make synaptic contacts with septo-hippocampal neurons . In addition to this direct projection, the hippocampus may influence the MS/DB complex by way of a glutamatergic, excitatory projection from the hippocampal pyramidal neurons to the lateral septal nucleus Alonso and Kohler 1982; Leranth and Frotscher 1989; Gaykema et al. 1991a ) which in turn projects to the MS/DB complex. This lateral septum to MS/DB projection has a restricted but detectable extent (Witter et al. 1992) . Similarly, projections from cortical areas to basal forebrain have been described . The prefrontal cortex constitutes the major source of cortical afferents to BF regions Vertes 2004) , and although initial studies suggested that this prefrontal input contacted cholinergic cells in the BF (Gaykema et al. 1991b) , later electron microscopic studies showed that the glutamatergic prefrontocortical afferents to BF closely apposed cholinergic cells, but could not unequivocally be shown to make synaptic contacts with them. In contrast, prefrontocortical afferents were shown to make synaptic contacts with parvalbumin positive, GABAergic neurons and also with parvalbumin negative and probably noncholinergic neuronal elements ). This latter component might include prefrontal glutamatergic input onto local or projection glutamatergic neurons in BF, which, to our knowledge, has not yet been proven experimentally but has recently been hypothesized ).
The present results indicate that 5-HT 4 receptors are synthesized by several of the above-mentioned neuronal populations. The main association of 5-HT 4 receptor synthesis in the BF seems to be with GABAergic cells, since approximately one-half of the GABAergic cells in MS/DB complex contains 5-HT 4 receptor mRNA and, conversely, a majority (between one-half and two-thirds) of 5-HT 4 receptor-synthesizing cells are GABAergic. Moreover, in the NbM, all the 5-HT 4 receptor-synthesizing cells were found to be GABAergic. In an attempt to further identify the nature of the GABAergic cells that synthesize 5-HT 4 receptors, parvalbumin was used as a marker of the GABAergic projection cell population (Freund 1989; Gritti et al. 2003) . Only a minor portion, between 10 and 15 %, of the 5-HT 4 receptor mRNApositive neurons in the MS/DB complex were positive for the marker parvalbumin. Thus, the combined results obtained from experiments with probes for parvalbumin and GAD65 mRNAs indicate that only a minor fraction of basal forebrain 5-HT 4 receptors located in GABAergic cells are on projection neurons, whereas a major fraction is located on GABAergic interneurons. However, when one considers the population of Parvalbumin-containing GABAergic projection cells, a significant fraction (from approximately 25 % in the MS/VDB to almost 50 % in the HDB area) of these cells expresses 5-HT 4 receptors, thus suggesting that these receptors may also have a prominent and direct role in the modulation of the BF GABAergic projection system. An association of 5-HT 4 receptors was also observed with glutamatergic cells, as defined by their expression of the vesicular glutamate transporter vGLUT2 (Lin et al. 2003; Hur and Zaborszky 2005) . Thus, about 20-25 % of the cells that synthesize 5-HT 4 receptors are glutamatergic in the MS/VDB complex and HDB, whereas when one considers the population of glutamatergic cells, around 30 and 65 % of these cells express 5-HT 4 receptor mRNA in these two areas, respectively. It remains to be established whether glutamatergic cells expressing 5-HT 4 receptors correspond to projection neurons, local circuit neurons or both. Nevertheless, since a majority of glutamatergic cells in the MS/DB complex are in fact local circuit neurons Manseau et al. 2005) , and given the high fraction (30-65 %) of glutamatergic cells that express 5-HT 4 receptors, it can be presumed that at least a fraction of the local BF glutamatergic neurons express 5-HT 4 receptors.
In contrast, BF cholinergic cells were never seen to contain detectable levels of mRNA for 5-HT 4 receptors. Thus, the present results suggest that any effect that 5-HT 4 receptor activation may have on acetylcholine release is likely to be mediated by non-cholinergic cell populations that do express this receptor.
As mentioned above, hippocampus and cortex (namely prefrontal cortex) also project to basal forebrain. 5-HT 4 receptors are expressed in some of the populations that provide these afferents to BF. Thus, in the indirect hippocampo-lateral septum-MS/DB projection, 5-HT 4 receptors are present at two different levels, i.e., in the glutamatergic, thus excitatory, hippocampal pyramidal neurons and in the GABAergic, thus inhibitory, cells of the dorsal part of the lateral septum, which have been shown to project to the VDB (Witter et al. 1992) . In contrast, the direct hippocampo-MS/DB projection arising from non-pyramidal GABAergic neurons is devoid of 5-HT 4 receptors, as indicated by the fact that 5-HT 4 receptor mRNA was not observed in hippocampal neurons that express the GABAergic marker GAD65. In the case of cortical afferents to basal forebrain, 5-HT 4 receptors are expressed by a fraction of glutamatergic projection neurons in the prefrontal cortex (Feng et al. 2001 and our own unpublished observations), although it remains to be established experimentally whether they are present specifically in the corticobasal neurons.
Functional considerations
Several studies have shown an involvement of 5-HT 4 receptors in the control of acetylcholine release. In the following paragraphs, an attempt will be made to provide an anatomical substrate for the observed functional effects of stimulation of 5-HT 4 receptors on ACh release in the light of the data presented herein. Many of the studies that have addressed the effects of activation of 5-HT 4 receptors on the release of acetylcholine have concentrated in the frontal or prefrontal cortex (Consolo et al. 1994; Yamaguchi et al. 1997a, b; Siniscalchi et al. 1999; Johnson et al. 2012) . Some of these studies demonstrate that activation of 5-HT 4 receptors enhances the release of ACh in these cortical areas, but the fact that drugs are applied systemically or intracerebroventricularly precludes the assignment of the receptors involved to particular cellular populations (Consolo et al. 1994; Nair and Gudelsky 2005; Johnson et al. 2012) . Another series of in vivo microdialysis experiments have shown that enhancement of serotonergic transmission either by serotonin reuptake inhibitors or by serotonin releasing agents results in increased release of ACh in frontal cortex which is blocked by 5-HT 4 receptor antagonists applied locally in the frontal cortex through the dialysis probe (Yamaguchi et al. 1997a, b; Nair and Gudelsky 2005) . Given the presence of 5-HT 4 receptor mRNA in frontocortical glutamatergic projection neurons (Feng et al. 2001 and our own unpublished observations) and its absence from cholinergic BF neurons described in the present study, it is possible that the 5-HT 4 receptors in frontal cortex that control the release of ACh correspond to the receptors located in glutamatergic projection neurons. Activation of these receptors could result in excitation of these glutamatergic neurons, which could in turn excite neuronal elements in the basal forebrain. One possible target of this frontocortical excitatory input to BF could be the cholinergic neurons themselves, although, as mentioned in preceding paragraphs, direct and unequivocal ultrastructural evidence of glutamatergic prefrontocortical input to BF cholinergic neurons does not exist. Another possible target would be other BF glutamatergic interneurons, which could then contact and excite cholinergic neurons. In Brain Struct Funct (2015) 220:3413-3434 3427 support of this, it has been shown that vGLUT2-positive puncta exist in close proximity to cholinergic, GABAergic and glutamatergic MS/DB neurons and that strong glutamatergic responses are detected in identified cholinergic, GABAergic and glutamatergic neurons in MS/DB . In addition, vGLUT1 and vGLUT2 synapses have been described on BF cholinergic cells, and these latter have been proposed to arise, at least in part, from glutamatergic vGLUT2-expressing neurons in the BF itself (Hur et al. 2009 ). Furthermore, several indications support a role for glutamate in the facilitation of ACh release in the cortex. Thus, it has been shown that excitation of the prefrontal cortex by local perfusion of the glutamatergic agonist AMPA dose-dependently increases ACh efflux in parietal cortex (Nelson et al. 2005) . Also, it has been shown that microinjection of glutamate into NbM results in increased activity of NbM cholinergic neurons as measured by high-affinity choline uptake in prefrontal cortex (Wenk 1984) and increased cortical ACh release (Kurosawa et al. 1989) . Thus, the anatomical and neurochemical bases exist to support an involvement of 5-HT 4 receptors present in glutamatergic projection neurons of the frontal cortex in the control of cortical ACh release. Activation of 5-HT 4 receptors present in the NbM by local application of a 5-HT 4 receptor agonist has been shown to enhance the acquisition and consolidation of spatial memory, an effect allegedly due to a potentiation of the activity of the cholinergic NbM-cortical pathways (Orsetti et al. 2003) . However, our present findings showing a lack of expression of 5-HT 4 receptors in cholinergic cells in the NbM together with their expression in GABAergic cells located in this brain area suggest that the NbM cholinergic system is not the direct recipient of this 5-HT 4 influence. This is supported by the fact that local application into NbM of indeloxazine, an inhibitor of 5-HT and noradrenaline reuptake with a facilitatory effect on 5-HT release, is unable to alter ACh release in frontal cortex (Yamaguchi et al. 1997b ). Thus, it seems possible that the promnesic effect observed after 5-HT 4 receptor agonist administration into the NbM (Orsetti et al. 2003 ) is mediated by corticopetal GABAergic neurons, which have been suggested to participate in the cognitive functions of the basal forebrain-cortical circuitry (Baxter and Chiba 1999; Semba 2000; Sarter and Bruno 2002) . Furthermore, it has been shown that a major proportion of the serotonergic innervation from the dorsal raphe nucleus to the substantia innominata and NbM seems to establish contacts with noncholinergic cells (Gasbarri et al. 1999) , thus suggesting that the 5-HT 4 -endowed GABAergic neurons in NbM may indeed receive serotonergic input in normal physiological conditions. Several other studies have addressed the effects of activation of 5-HT 4 receptors on the release of acetylcholine in the hippocampus. An in vivo microdialysis study has shown that local application of a 5-HT 4 receptor agonist in the hippocampus results in increased levels of hippocampal ACh (Matsumoto et al. 2001) . A direct P-labeled probes for 5-HT 4 receptor mRNA and with digoxigenin-labeled probes for glutamic acid decarboxylase (GAD65) mRNA. Upper row CA1 region; middle row CA3 region; lower row dentate gyrus. a, c, e Images obtained after superimposing dark-and bright-field photomicrographs with the AnalySIS software. b, d, f High-magnification photomicrographs of the frames in a, c, e taken with a Darklite illuminator showing dark-and bright-field simultaneously. Note how the cells that contain GAD65 mRNA (dark precipitate) do not contain 5-HT 4 receptor mRNA (silver grains). Scale bars 100 lm in a, 25 lm in b effect of the agonist on cholinergic terminals to facilitate ACh release is not supported by the present results of a lack of expression of 5-HT 4 receptor mRNA in cholinergic neurons of MS/VDB. Given the high levels of expression of 5-HT 4 receptors in the hippocampus itself (Waeber et al. 1994; Vilaró et al. 2005 and present results), it is likely that these are the receptors that mediate the facilitating effect on ACh release. We have shown that the expression of 5-HT 4 receptor mRNA in the hippocampus is restricted to the populations of principal cells, i.e., the glutamatergic pyramidal cells of Cornu Ammonis and granule cells of the dentate gyrus, whereas hippocampal GABAergic neurons, that include interneurons and long-range projection neurons (Freund and Buzsaki 1996) , are devoid of 5-HT 4 receptor mRNA. The question arises as to which is the neuronal circuitry responsible for the ultimate activation of MS/DB cholinergic neurons that results in enhancement of ACh release in the hippocampus in response to hippocampal 5-HT 4 receptor activation. A direct glutamatergic projection from hippocampal pyramidal neurons to MS/DB complex was postulated in earlier studies (Walaas and Fonnum 1980; Alonso and Kohler 1982) , but it has not been further substantiated, therefore lending little support to its involvement in the observed effects on ACh release. On the other hand, it has been shown that pyramidal cells of CA1 project to the prefrontal cortex, contacting both pyramidal projection neurons and interneurons (Carr and Sesack 1996; Gabbott et al. 2002) , and that hippocampal stimulation results in excitation of most of the recorded pyramidal neurons in the prefrontal cortex (Degenetais et al. 2003) . Thus, it is conceivable that 5-HT 4 -mediated excitation of hippocampal projection neurons results in excitation of prefrontocortical pyramidal neurons which, in turn, may project to the basal forebrain Vertes 2004 ) and ultimately elicit excitation of cholinergic septo-hippocampal cells possibly by involving local circuit glutamatergic excitatory MS/DB neurons . A further possible circuit might involve the GABAergic hippocampal projection neurons. Thus, 5-HT 4 receptor-mediated excitation of pyramidal neurons would result in excitation of non-principal GABAergic neurons with which they are connected (Freund and Buzsaki 1996; Somogyi et al. 1998) . Some of these GABAergic cells are local circuit neurons, but others project to the MS/DB region Freund and Buzsaki 1996) , where they mainly contact, and likely inhibit, parvalbumin-containing GABAergic neurons . Inhibition of these inhibitory MS/DB neurons, which make local recurrent contacts with cholinergic septo-hippocampal cells (Leranth and Frotscher 1989) could eventually result in disinhibition of cholinergic neurons and thus in increased ACh output in the hippocampus. receptor mRNA in the different neuronal populations present in the basal forebrain and its hippocampal and cortical targets that have been analyzed in the present study. Known projections between the different cell populations have also been depicted. Colors indicate the different neurotransmitter phenotypes known to exist in these areas and identified in our study by in situ hybridization. Numbers close to the cell type or to the axonal projections indicate the literature references. White dots within neuronal cell bodies indicate expression of 5-HT 4 receptor mRNA. Outlines of coronal brain sections were taken from the atlas of Paxinos and Watson (1997) . Gra granule cell layer of dentate gyrus, LS lateral septal nucleus, MS-DB complex medial septum-diagonal band complex, NbM nucleus basalis of Meynert, PrFCx prefrontal cortex, Pyr pyramidal cell layer of Finally, other studies have used slices from different brain regions to address the effects of 5-HT 4 receptor stimulation on ACh release. Thus, stimulation of 5-HT 4 receptors increased electrically stimulated 3 H-choline efflux from slices from guinea pig fronto-parietal cortex and hippocampus and from rat hippocampus (Siniscalchi et al. 1999) . In contrast, in hippocampal synaptosomal preparations also tested in the study, superfusion with a 5-HT 4 receptor agonist did not modify 3 H-choline efflux (Siniscalchi et al. 1999) . The lack of effect on synaptosomes would be in agreement with the lack of expression of 5-HT 4 receptors in cholinergic neurons reported herein. In the slice preparations, the observed effects cannot be mediated by circuitry involving distant brain regions, thus local events must be involved. In the rat hippocampal slice preparation, 5-HT 4 receptors are located on glutamatergic neurons, as indicated by the present results. Similarly, it can be assumed, by analogy with the rat (Vilaró et al. 2005) , that in the guinea pig cortical and hippocampal slice preparations 5-HT 4 receptors are also located on glutamatergic pyramidal neurons. Thus, an activation of these hippocampal or cortical 5-HT 4 receptors may result in excitation of these neurons and in increased glutamate release within the slice. This glutamate might in turn be able to modulate ACh release provided that glutamate receptors exist on cholinergic terminals. Support for this localisation comes from the fact that, in cortical synaptosomal preparations, activation of AMPA type glutamate receptors enhances the release of [ 3 H]ACh (Ghersi et al. 2003) , thus indicating the presence of AMPA receptors on cholinergic terminals. Furthermore, it has been shown that cholinergic basal forebrain neurons express several of the glutamate receptor subunits (GluR1-4) that form AMPA receptors (Martin et al. 1993; Page and Everitt 1995) , and AMPA receptors have been detected in presynaptic locations in the hippocampus (Fabian-Fine et al. 2000) . Interestingly, in this latter study, AMPA receptors have been described on presynaptic axon terminals that in turn receive axo-axonic synapses, of a putative excitatory nature.
In conclusion, the present results lend support to the absence of 5-HT 4 receptors from cholinergic BF neurons and point to the involvement of GABAergic and/or glutamatergic cell populations within the BF itself or in cortical and hippocampal regions in the enhancement of acetylcholine release elicited by 5-HT 4 receptor agonists. These neuroanatomical data provide the basis for more detailed microdialysis and/or tract tracing studies that should result in deeper knowledge of the circuits involved in the observed pro-cognitive effects elicited by activation of 5-HT 4 receptors.
